MedTrace Logo

COPD and Socially Vulnerable Individuals

NCT04754308 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 513

Last updated 2024-04-29

No results posted yet for this study

Summary

The trial investigates and describes the prevalence of COPD in patients who are in the social nurses' target group and investigates the effect of opportunistic screening for COPD in these vulnerable patients.

The study population is patients who have been referred to a social nurse at hospitals in the Capital Region, Central Denmark Region and Region Zealand of Denmark during the inclusion period, and monitor them for up to 5 years in order to investigate variables that are significant in terms of the patients' treatment, hospitalisations, and mortality in relation to COPD.

Our hypothesis is that there will be a higher incidence of COPD among those patients with whom the social nurses have contact than in the general population.

Conditions

Interventions

DIAGNOSTIC_TEST

Spirometry

The method of examination, Spirometry, is non-invasive (i.e. not an intervention that involves penetration into the body by means of incisions or injections.). It is a routine examination and there are no risks, adverse reactions, or discomforts associated with the examination.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care

    collaborator OTHER

  • Hvidovre University Hospital

    lead OTHER

Principal Investigators

  • Nina Brünés · Amager and Hvidovre Hospital, Patientforloeb

  • Charlotte Ulrik · Amager and Hvidovre Hospital, Medical Department

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2024-04-18
Completion
2024-04-18

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04754308 on ClinicalTrials.gov